NCT05755035: A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases |
|
|
| Recruiting | 2/3 | 75 | Europe, US, RoW | TAK-881, Immune Globulin Subcutaneous (Human), 20% Solution with Recombinant Human Hyaluronidase (rHuPH20)., HYQVIA, Immune Globulin Infusion (Human), 10% Solution with rHuPH20. | Takeda, Takeda Development Center Americas, Inc. | Primary Immunodeficiency Diseases (PID) | 02/26 | 09/26 | | |
NCT05984589: Personalized Self-Management Training Compared to Standardized Self-Management Training in Colorectal Cancer Patients. |
|
|
| Recruiting | 2 | 120 | US | RISE Personalized Self-Managament Training (PSMT), Standardized Self-Managament Training (SSMT) | Arash Asher, MD, National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Colorectal Cancer, Healthy Lifestyle, Behavior, Health, Health Behavior | 02/26 | 02/26 | | |
